Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways

Human Molecular Genetics

Volumn 13, Issue 12, 2004, Pages 1241-1248

  Hussain, Shobbir ^a   Wilson, James B ^b   Medhurst, Annette L ^c   Hejna, James ^d   Witt, Emily ^e   Ananth, Sahana ^b   Davies, Adelina ^f   Masson, Jean Yves ^g   Moses, Robb ^d   West, Stephen C ^f   de Winter, Johan P ^c   Ashworth, Alan ^e   Jones, Nigel J ^b   Mathew, Christopher G ^a,h  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^g UNIVERSITÉ LAVAL   (Canada)

^h GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CELL EXTRACT; HYDROXYUREA; MITOMYCIN C; MUTANT PROTEIN; NUCLEAR PROTEIN; RAD51 PROTEIN; RAD52 PROTEIN; RAD54 PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; PARALOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

ANIMALS; BRCA2 PROTEIN; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CRICETINAE; DNA DAMAGE; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HUMANS; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; RAD51 RECOMBINASE; TWO-HYBRID SYSTEM TECHNIQUES; YEASTS;

CRICETINAE; CRICETULUS GRISEUS;

EID: 3042858785     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh135     Document Type: Article

References (60)

1. Joenje, H., Oostra, A.B., Wijker, M., di Summa, F.M., van Berkel, C.G., Rooimans, M.A., Ebell, W., van Weel, M., Pronk, J.C., Buchwald, M. et al. (1997) Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet., 61, 940-944.
2. Levitus, M., Rooimans, M.A., Steltenpool, J., Cool, N.F.C., Oostra, A.B., Mathew, C.G., Hoatlin, M.E., Waisfisz, Q., Arwert, F., de Winter, J.P. et al. (2004) Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood, 103, 2498-2503.
3. Strathdee, C.A., Gavish, H., Shannon, W.R. and Buchwald, M. (1992) Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature, 358, 763-767 (correction: Nature, 358, 434).
4. Lo Ten Foe, J.R., Rooimans, M.A., Bosnoyan-Collins, L., Alon, N., Wijker, M., Parker, L., Lightfoot, J., Carreau, M., Callen, D.F., Savoia, A. et al. (1996) Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet., 14, 320-323.
5. Fanconi Anaemia/Breast Cancer Consortium (1996) Positional cloning of the Fanconi anemia group A gene. Nat. Genet., 14, 324-328.
6. de Winter, J.P., Waisfisz, Q., Rooimans, M.A., Van Berkel, C.G.M., Bosnoyan-Collins, L., Alon, N., Carreau, M., Bender, O., Demuth, I., Schindler, D. et al. (1998) The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat. Genet., 20, 281-283.
7. de Winter, J.P., Leveille, F., van Berkel, C.G., Rooimans, M.A., van Der Weel, L., Steltenpool, J., Demuth, I., Morgan, N.V., Alon, N., Bosnoyan-Collins, L. et al. (2000) Isolation of a cDNA representing the Fanconi Anemia complementation group E gene. Am. J Hum. Genet., 67, 1306-1308.
8. de Winter, J.P., Rooimans, M.A., van Der Weel, L., van Berkel, C.G., Alon, N., Bosnoyan-Collins, L., de Groot, J., Zhi, Y., Waisfisz, Q., Pronk, J.C. et al. (2000) The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet., 24, 15-16.
9. Timmers, C., Taniguchi, T., Hejna, J., Reifsteck, C., Lucas, L., Bruun, D., Thayer, M., Cox, B., Olson, S., D'Andrea, A.D. et al. (2001) Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell, 7, 241-248.
10. Howlett, N.G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609.
11. Meetei, A.R., de Winter, J.P., Medburst, A.L., Wallisch, M., Waisfisz, Q., van de Vrugt, H.J., Oostra, A.B., Yan, Z., Ling, C., Bishop, C.E. et al. (2003) A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet., 35, 165-170.
12. Kupfer, G.M., Näf, D., Suliman, A., Pulsipher, M. and D'Andrea, A.D. (1997) The Fanconi anaemia proteins, FAA and FAC interact to form a nuclear complex. Nat. Genet., 17, 487-490.
13. Garcia-Higuera, I., Kuang, Y., Näf, D., Wasik J. and D'Andrea, A.D. (1999) Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell. Biol., 19, 4866-4873.
14. de Winter, J.P., van Der Weel, L., de Groot, J., Stone, S., Waisfisz, Q., Arwert, F., Scheper, R.J., Kruyt, F.A., Hoatlin, M.E. and Joenje, H. (2000) The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet., 9, 2665-2674.
15. Medhurst, A.L., Huber, P.A., Waisfisz, Q., de Winter, J.P. and Mathew, C.G. (2001) Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet., 10, 423-429.
16. Pace, P., Johnson, M., Tan, W.M., Mosedale, G., Sng, C., Hoatlin, M.E., de Winter, J.P., Gergely, F. and Patel, K.J. (2002) FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J., 21, 3414-3423.
17. Meetei, A.R., Sechi, S., Wallisch, M., Yang, D., Young, M.K., Joenje, H., Hoatlin, M.E. and Wang, W. (2003) A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol., 23, 3417-3426.
18. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M. and D'Andrea, A.D. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell, 7, 249-262.
19. D'Andrea, A.D. and Grompe, M. (2003) The Fanconi anemia/BRCA pathway. Nat. Rev. Can., 3, 23-34.
20. Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H.V., Mathew, C.G., Kastan, M.B., Weaver, D.T. and D'Andrea, A.D. (2002) Interaction of FANCD2 and NBS1 in the DNA crosslink response. Nat. Cell Biol., 4, 913-920.
21. Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P.R., Gregory, R.C., Kim, S.T., Lane, W.S., Kastan, M.B. and D'Andrea, A.D. (2002) Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell, 109, 459-472.
22. Houghtaling, S., Timmers, C., Noll, M., Finegold, M.J., Jones, S.N., Meyn, M.S. and Grompe, M. (2003) Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev., 17, 2021-2035.
23. Rothfuss, A. and Grompe, M. (2004) Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell Biol., 24, 123-134.
24. West, S.C. (2003) Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol., 4, 435-445.
25. Hussain, S., Witt, E., Huber, P.A.J., Ashworth, A. and Mathew, C.G. (2003) Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet., 12, 2503-2510.
26. Gordon, S.M. and Buchwald, M. (2003) Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood, 102, 136-141.
27. Wilson, J.B., Johnson, M.A., Stuckert, A.P., Trueman, K.L., May, S., Bryant, P.E., Meyn, R.E., D'Andrea, A.D. and Jones, N.J. (2001) The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange. Carcinogenesis, 22, 1939-1946.
28. Goggins, M., Schutte, M., Lu, J., Moskaluk, C.A., Weinstein, C.L., Petersen, G.M., Yeo, C.J., Jackson, C.E., Lynch, H.T., Hruban, R.H. et al. (1996) Germline BRC42 gene mutations in patients with apparently sporadic pancreatic carcinomas. Can. Res., 56, 5360-5364.
29. Davies, A.A., Masson, J.Y., McIlwraith, M.J., Stasiak, A.Z., Stasiak, A., Venkitaraman, A.R. and West, S.C. (2001) Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell, 7, 273-282.
30. Pellegrini, L., Yu, D.S., Lo, T., Anand, S., Lee, M., Blundell, T.L. and Venkitaraman, A.R. (2002) Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nat. Cell Biol., 420, 287-293.
31. Yu, D.S., Sonoda, E., Takeda, S., Huang, C.L.H., Pellegrini, L., Blundell, T.L. and Venkitaraman, A.R. (2003) Dynamic control of RAD51 recombinase by self-association and interaction with BRCA2. Mol. Cell, 12, 1029-1041.
32. Wong, A.K., Pero, R., Ormonde, P.A., Tavtigian, S.V. and Bartel, P.L. (1997) RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRCA2. J. Biol. Chem., 272, 31941-31944.
33. Chen, P.L., Chen, C.F., Chen, Y., Xiao, J., Sharp, Z.D. and Lee, W.H. (1998) The BRC repeats in BRCA2 are critical for Rad51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl Acad. Sci. USA, 95, 5287-5292.
34. Yuan, S.S., Lee, S.Y., Chen, G., Song, M., Tomlinson, G.E. and Lee, E.Y. (1999) BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Can. Res., 59, 3547-3551.
35. Taniguchi, T., Garcia-Higuera, I., Andreassen, P.R., Gregory, R.C., Grompe, M. and D'Andrea, A.D. (2002) S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, 100, 2414-2420.
36. Michel, B., Ehrlich, S.D. and Uzest, M. (1997) DNA double-strand breaks caused by replication arrest. EMBO J., 16, 430-438.
37. Scully, R., Chen, J., Ochs, R.L., Keegan, K., Hockstra, M., Feunteun, J. and Livingston, D.M. (1997) Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90, 425-435.
38. Hirsch, B., Shimamura, A., Moreau, L., Baldinger, S., Hag-alshiekh, M., Bostrom, B., Sencer, S. and D'Andrea, A.D. (2004) Biallelic BRCA2/FANCD1 mutations: association with spontaneous chromosomal instability and solid tumors of childhood. Blood, 103, 2554-2559.
39. Li, M., Brooks, C.L., Wu-Baer, F., Chen, D., Baer, R. and Gu, W. (2003) Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science, 302, 1972-1975.
40. Vandenberg, C.J., Gergely, F., Ong, C.Y., Pace, P., Mallery, D.L., Hiom, K. and Patel, K.J. (2003) BRCA1-independent ubiquitination of FANCD2. Mol. Cell, 12, 247-254.
41. Raderschall, E., Golub, E.I. and Haaf, T. (1999) Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc. Natl Acad. Sci. USA, 96, 1921-1926.
42. Dronkert, M.L. and Kanaar, R. (2001) Repair of DNA interstrand cross-links. Mutat. Res., 486, 217-247.
43. McHugh, P.J., Spanswick, V.J. and Hartley, J.A. (2001) Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol., 2, 483-490.
44. Vaughn, J.P., Cirisano, F., Huper, G., Bergchuk, A., Futreal, P.A., Marks, J.R. and Iglehart, J.D. (1996) Cell cycle control of BRCA2. Can. Res., 56, 4590-4594.
45. Chen, J., Silver, D.P., Walpita, D., Cantor, S.B., Gazdar, A.F., Tomlinson, G.E., Couch, F.J., Weber, B.L., Ashley, T., Livingston, D.M. et al. (1998) Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell, 2, 317-328.
46. Lomonosov, M., Anand, S., Sangrithi, M., Davies, R. and Venkitaraman, A.R. (2003) Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev., 17, 3017-3022.
47. Bjelland, S. and Seeberg, E. (2003) Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat. Res., 531, 37-80.
48. Cox, M.M., Goodman, M.F., Kreuzer, K.N., Sherratt, D.J., Sandler, S.J. and Marians, K.J. (2000) The importance of repairing stalled replication forks. Nature, 404, 37-41.
49. Yamamoto, K., Ishiai, M., Matsushita, N., Arakawa, H., Lamerdin, J.E., Buerstedde, J.M., Tanimoto, M., Harada, M., Thompson, L.H. and Takata, M. (2003) Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol., 23, 5421-5430.
50. Shin, D.S., Pellegrini, L., Daniels, D.S., Yelent, B., Craig, L., Yu, D.S., Shivji, M.K., Hitmi, C., Arvai, A.S., Volkmann, N. et al. (2003) Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2. EMBO J., 22, 4566-4576.
51. Folias, A., Matkovic, M., Bruun, D., Reid, S.,Hejna, J., Grompe, M., D'Andrea, A.D. and Moses, R. (2002) BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet., 11, 2591-2597.
52. Marston, N.J., Richards, W.J., Hughes, D., Bertwistle, D., Marshall, C.J. and Ashworth, A. (1999) Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol. Cell. Biol., 19, 4633-4642.
53. Huber, P.A., Medhurst, A.L., Youssoufian, H. and Mathew, C.G. (2000) Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis. Biochem Biophys. Res. Comm., 268, 73-77.
54. Johnson, M.A. and Jones, N.J. (1999) The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants; two new complementation groups of etoposide sensitive mutants. Mutat. Res./DNA Rep., 435, 227-238.
55. Warriar, N., Page, N. and Govindan, M.V. (1996) Expression of human glucocorticoid receptor gene and interaction of nuclear proteins with the transcriptional control element. J. Biol. Chem., 271, 18662-18671.
56. Lamerdin, J.E., Yamada, N.A., George, J.W., Souza, B., Christian, A.T., Jones, N.J. and Thompson, L.H. (2004) Characterization of the hamster FancG/Xrcc9 gene and mutations in CHO UV40 and NM3. Mutagenesis, 19, 237-244.
57. Qiao, F., Moss, A. and Kupfer, G.M. (2001) Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J. Biol. Chem., 276, 23391-23396.
58. Schild, D., Lio, Y., Collins, D.W., Tsomondo, T. and Chen, D.J. (2000) Evidence for simultaneous protein interactions between human Rad51 paralogs. J. Biol. Chem., 275, 16443-16449.
59. Masson, J.Y., Tarsounas, M.C., Stasiak, A.Z., Stasiak, A., Shah, R., McIlwraith, M.J., Benson, F.E. and West, S.C. (2001) Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev., 15, 3296-3307.
60. Liu, N., Lamerdin, J.E., Tebbs, R.S., Schild, D., Tucker, J.D., Shen, M.R., Brockman, K.W., Siciliano, M.J., Walter, C.A., Fan, W. et al. (1998) XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol. Cell, 1, 783-793.